KRAS and lung adenocarcinoma: The result indicated that KRAS mutation occurs more frequently in lung adenocarcinoma (RR=1.16 p=0.016), and in former or current smokers (RR=1.13 p=0.017), but not in male gender (RR=1.07 p=0.142) (Table S2).